Toregem BioPharma
PrivateLast Round
Early Funding
May 19, 2026
Total Funding Raised
$22.53M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Toregem BioPharma is a biopharmaceutical company developing regenerative therapeutics for tooth loss.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Toregem BioPharma Comparables
Compare Toregem BioPharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OrganTech Inc. | 65% | |
| HysensBio | 61% | |
| Air Water Inc. | 54% | |
Toregem BioPharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | May 19, 2026 | ||||
| Series B | Aug 30, 2024 | ||||
| Series A Extension | Jul 3, 2023 | ||||
| Series A | Mar 8, 2022 | ||||
| Seed | Apr 30, 2021 | ||||
Seed | May 12, 2020 |
Toregem BioPharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Chushin Venture Capital | Early Funding |
| Tohoku University Venture Partners | Series B, Series A Extension |
| JIC Venture Growth Investments | Early Funding, Series B, Series A Extension |
| Kyoto Capital Partners | Series B |
| Miraidoa | Series A |
| Astellas Venture Management | Series B, Series A Extension, Series A |
| Mitsubishi UFJ Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 19, 2026
$5.3M raised from multiple venture capital firms.
- Aug 30, 2024
$10.25M round with participation from Astellas Venture Management and SMBC Venture Capital.
Toregem BioPharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Toregem BioPharma's valuation, stock price, and market status.